Cost : $80-120 per month (research) Compare research vs pharmaceutical options
INTRODUCTION Stroke remains one of the leading causes of death and longterm disability, and the urgent quest for an effective therapeutic solution is evidenced by numerous failed clinical trials (Holloway & Gavins, 2016) but also in novel ways of trying to treat the disease (Amani, Habibey, et al., 2019
Dutta D, Nagendra L, Harish BG, et al
Use Proper Aseptic Technique: Proper storage is useless without proper handling
Molecular players and dynamic protein-protein interactions PNPLA2 is activated by co-regulator alpha/beta hydrolase domain-containing protein 5 PNPLA2, the rate limiting enzyme for TAG hydrolysis was initially identified independently in 2004 by the groups of Gross (21), Zechner (17) and Sul (28), with subsequent work from the Zechner group demonstrating PNPLA2 as the rate limiting step in TAG hydrolysis in vivo (29)